Qube Research & Technologies LTD Reviva Pharmaceuticals Holdings, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 50 shares of RVPH stock, worth $74. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 21,513
99.77%
Holding current value
$74
Previous $81,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RVPH
# of Institutions
37Shares Held
6.85MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$2.36 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.52 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$1.5 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT505KShares$746,8080.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $30.3M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...